13th Oct 2026 10:55
Verici Dx PLC - Cardiff, Wales-based developer of suite of tests for kidney transplant response risk - Shares resume trading in London on Tuesday, after Verici Dx raises GBP8.8 million in total from a placing and retail offer of shares, double its previous market capitalisation. The company had made use to the AIM market's capital access window to suspend trading in its shares during the equity raise. Verici Dx raised GBP8.5 million from a placing of 4.25 billion shares and retail offer of 125.0 million shares, both at 0.20 pence each. The placing is run by Singer Capital Markets and Oberon Capital, and the retail offer is via the Winterflood retail access platform.
Current stock price: 0.22p
12-month change: down 76%
By Tom Waite, Alliance News editor
Comments and questions to [email protected]
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Related Shares:
Verici Dx